News Author: Doug Brunk Publish date: December 21, 2021
“Additional prospective studies are still needed to further validate our findings,” Dr. Jordan V. Wang said.
News Author: Doug Brunk Publish date: December 17, 2021
Reimbursement rates were greatest in the Western geographic region of the United States.
News Author: Doug Brunk Publish date: December 17, 2021
“There is a need for us to further interrogate what the causes are for this disparity in care between rural and urban centers,” Dr. Bryan T. Carrol...
News Author: Doug Brunk Publish date: December 15, 2021
Morphological variants common in skin of color include the follicular variant or micropapular variant of AD.
News Author: Doug Brunk Publish date: December 15, 2021
“We know that responses to, and adverse events associated with, systemic therapies may vary among patients of different ages.”
News Author: Doug Brunk Publish date: December 15, 2021
“There is a consequence of not treating patients with atopic dermatitis, especially those patients with sleep disturbance.”
News Author: Doug Brunk Publish date: December 10, 2021
The three most common injection sites involving necrosis and vision changes were the cheek, the nose, and the nasolabial fold.
News Author: Doug Brunk Publish date: December 8, 2021
Twelve studies involving 459 patients from seven countries were included in the final analysis.
News Author: Doug Brunk Publish date: December 2, 2021
Counseling about systemic therapy includes shared decision-making, Dr. Lawrence F. Eichenfield says.
News Author: Doug Brunk Publish date: November 30, 2021
There is no perfect outcome measure yet, but progress is being made.
News Author: Doug Brunk Publish date: November 24, 2021
Difelikefalin is the first FDA-approved treatment for uremic pruritus associated with dialysis.
News Author: Doug Brunk Publish date: November 24, 2021
“The testing in research laboratories is not widely available and the results are often delayed by weeks to months.”
News Author: Doug Brunk Publish date: November 23, 2021
As for treating papules and pustules with oral agents, the strongest evidence favors oral tetracyclines and isotretinoin.
News Author: Doug Brunk Publish date: November 22, 2021
In 2020, clascoterone cream became the first topical androgen receptor inhibitor approved for the treatment of acne in patients aged 12 years and o...
News Author: Doug Brunk Publish date: November 11, 2021
Recent research shows that the endocannabinoid system is involved in modulation of the CNS and in immune function, particularly skin homeostasis an...